Potentiated topical composition
First Claim
1. A topical composition for administration of a pharmacologically active agent comprising a pharmacologically effective amount of said pharmacologically active agent, from 5% by weight to 35% by weight of pentane-1,5-diol and a cosmetically or pharmaceutically acceptable carrier,wherein the pharmacologically active agent is selected from the group consisting of steroids and thyroid hormones.
1 Assignment
0 Petitions
Accused Products
Abstract
A topical composition for skin care or administration of a pharmacologically active agent in form of a lotion, cream or similar comprises from 5% to 70% by weight of pentane-1,5-diol and a cosmetically or pharmaceutically acceptable carrier, with the proviso that the composition does not comprise polysiloxane, volatile siloxane, phosphatidyl-choline, creatine, carnitine, panthenol, pyruvic acid, monoglyceride of lauric acid, monoglyceride of myristic acid. Also disclosed are corresponding methods of administration, a patch for holding said composition against the skin, and methods of preventing or treating a dry skin condition and of keeping skin in a humid state.
19 Citations
18 Claims
-
1. A topical composition for administration of a pharmacologically active agent comprising a pharmacologically effective amount of said pharmacologically active agent, from 5% by weight to 35% by weight of pentane-1,5-diol and a cosmetically or pharmaceutically acceptable carrier,
wherein the pharmacologically active agent is selected from the group consisting of steroids and thyroid hormones.
-
6. The composition of 5, wherein the cosmetically or pharmaceutically acceptable carrier comprises less than 1% by weight of propane-1,2-diol, glycerol or a combination thereof.
- 14. A topical composition for administration of a pharmacologically active agent comprising a pharmacologically effective amount of said pharmacologically active agent, from 5% by weight to 15% by weight of pentane-1,5-diol and a cosmetically or pharmaceutically acceptable carrier, wherein the composition is a cream in which the pharmacological active agent is a thyroid hormone.
Specification